EOCN

Eocene Ltd

2.850

-0.200-6.55%

After Hours: 2.710 -0.140 -4.92%19:38 10/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.910/3.050

TODAY RANGE2.330-3.090

VOL10.99K

MARKET CAP2.97M

52 WEEK RANGE2.330-12.32

AVG VOL (3M)32.23K

% TURNOVER1.04%

TURNOVER--

P/E (TTM)-0.1985

% RANGE24.92%

EPS(TTM)-14.3577

P/E(FORWARD)-0.2498

P/B0.2241

BVPS12.72

DIVIDEND--

P/S3.632

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.88M

SHARES OUTSTANDING1.04M

NEXT EARNINGS11/24-11/30

FREE FLOAT1.01M

LOT SIZE1

EX-DATE08/19/2026

News

Press Releases

Financial Reports

Profile

TipRanks·09/10 18:40
Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)
NASDAQ·09/09 15:06
Galmed Pharma Rebrands To EoCene, Debuts EOCN Ticker As GI Expansion Accelerates; Stock Up
TipRanks·09/09 12:33
Galmed Rebrands as EoCene, Secures Nasdaq Compliance and Ends Yorkville Equity Line
PR Newswire·09/09 11:30
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
TipRanks·09/08 10:31
Galmed Pharmaceuticals Regains Nasdaq Bid-Price Compliance, Avoids Delisting Risk
NASDAQ·09/04 02:47
6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More
TipRanks·09/03 23:30
Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGM
TipRanks·09/02 21:18
Galmed Pharmaceuticals Posts Higher R&D Spend and Shrinking Cash in Q2 2026
TipRanks·09/02 20:27
Galmed Pharmaceuticals Adjourns Shareholder Meeting for Lack of Quorum
TipRanks·08/19 11:28
Galmed’s Colospan Unit Reports Successful First-in-Human Study for New Colorectal Surgery Platform
TipRanks·08/19 11:15
Colospan completes feasibility study of new assesment platform
TipRanks·08/18 23:50
Galmed trading halted, news pending
TipRanks·08/17 13:49
Galmed Reports Aramchol–Xtandi Combo Boosts Prostate Cancer Cell Death in Pre-Clinical Study
TipRanks·08/17 13:20
Galmed reports results from study of a combination of Aramchol and Xtandi
TipRanks·08/14 21:22
Galmed Pharmaceuticals to Enact 1-for-8 Reverse Share Split Effective August 19, 2026

Same Industry

Name/Symbol

Change%

Price

EOCN

REGN

GridAI Tech

GRDX

-6.24%

4.660

BIONTECH

BNTX

-7.13%

89.01

United Therapeutics Corp.

UTHR

+0.17%

550.10

Vertex Pharmaceuticals Inc

VRTX

-4.30%

485.22

Siga Technologie

SIGA

-3.66%

3.160

Moderna

MRNA

+1.17%

216.25

CRL

Medpace Holdings

MEDP

+1.55%

612.05

Talphera Inc

TLPH

0.00%

1.080

ICON plc

ICLR

-0.20%

164.17

CBPO

Iqvia Hldgs Inc

IQV

+0.51%

262.01

MOLECULAR PARTNERS AG

MOLN

+1.05%

3.850

Arcturus Therape

ARCT

-7.56%

11.12

Gilead Sciences Inc

GILD

-0.75%

156.19

PRAH

INCY

Aptevo Therapeutics Inc

APVO

-0.56%

1.790

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.